S. Muthu, Madhan Jeyaraman, Girinivasan Chellamuthu, A. Manivannan, M. Khanna
{"title":"SARS-CoV-2时代骨科风湿病学策略建议及实践原则","authors":"S. Muthu, Madhan Jeyaraman, Girinivasan Chellamuthu, A. Manivannan, M. Khanna","doi":"10.18231/J.IJOR.2020.010","DOIUrl":null,"url":null,"abstract":"WHO declared SARS-CoV-2 as a pandemic disease on 11th March 2020. Due to global lockdown and restricted social movements, there is a rising curve in the morbidity of health of non- SARS-CoV-2 orthopaedic rheumatology patients and an impairment in the functional quality of life necessitating a pandemic response protocol into action in all fields of patient care. The development of ideal strategies and recommendations for the management of orthopaedic rheumatologically predisposed population and principles to be followed in their practice is the need of the hour. We hereby give a comprehensive list of strategies that can be followed in orthopaedic rheumatology practice by encompassing the recommendations given by the European League Against Rheumatism (EULAR), The American College of Rheumatologists (ACR), and Indian Association of Orthopaedic Rheumatology - Indian Orthopaedic Association (IORA-IOA). SARS-CoV-2 pandemic has put enormous pressure on patients with Rheumatic Diseases (RD) due to their innate weakness and shared treatment protocols in management. Though RD\nneeds a multidisciplinary approach, which remains a challenge in this pandemic scenario, these strategic recommendations would aid in their optimal care amidst the adversity of SARS-CoV-2.\n\nKeywords: Orthopaedic Rheumatology, SARSCoV2, COVID19, Rheumatic Diseases.","PeriodicalId":274774,"journal":{"name":"IP International Journal of Orthopaedic Rheumatology","volume":"97 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Orthopaedic rheumatology strategic recommendations and practice principles in SARS-CoV-2 Era\",\"authors\":\"S. Muthu, Madhan Jeyaraman, Girinivasan Chellamuthu, A. Manivannan, M. Khanna\",\"doi\":\"10.18231/J.IJOR.2020.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"WHO declared SARS-CoV-2 as a pandemic disease on 11th March 2020. Due to global lockdown and restricted social movements, there is a rising curve in the morbidity of health of non- SARS-CoV-2 orthopaedic rheumatology patients and an impairment in the functional quality of life necessitating a pandemic response protocol into action in all fields of patient care. The development of ideal strategies and recommendations for the management of orthopaedic rheumatologically predisposed population and principles to be followed in their practice is the need of the hour. We hereby give a comprehensive list of strategies that can be followed in orthopaedic rheumatology practice by encompassing the recommendations given by the European League Against Rheumatism (EULAR), The American College of Rheumatologists (ACR), and Indian Association of Orthopaedic Rheumatology - Indian Orthopaedic Association (IORA-IOA). SARS-CoV-2 pandemic has put enormous pressure on patients with Rheumatic Diseases (RD) due to their innate weakness and shared treatment protocols in management. Though RD\\nneeds a multidisciplinary approach, which remains a challenge in this pandemic scenario, these strategic recommendations would aid in their optimal care amidst the adversity of SARS-CoV-2.\\n\\nKeywords: Orthopaedic Rheumatology, SARSCoV2, COVID19, Rheumatic Diseases.\",\"PeriodicalId\":274774,\"journal\":{\"name\":\"IP International Journal of Orthopaedic Rheumatology\",\"volume\":\"97 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"IP International Journal of Orthopaedic Rheumatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18231/J.IJOR.2020.010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"IP International Journal of Orthopaedic Rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18231/J.IJOR.2020.010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Orthopaedic rheumatology strategic recommendations and practice principles in SARS-CoV-2 Era
WHO declared SARS-CoV-2 as a pandemic disease on 11th March 2020. Due to global lockdown and restricted social movements, there is a rising curve in the morbidity of health of non- SARS-CoV-2 orthopaedic rheumatology patients and an impairment in the functional quality of life necessitating a pandemic response protocol into action in all fields of patient care. The development of ideal strategies and recommendations for the management of orthopaedic rheumatologically predisposed population and principles to be followed in their practice is the need of the hour. We hereby give a comprehensive list of strategies that can be followed in orthopaedic rheumatology practice by encompassing the recommendations given by the European League Against Rheumatism (EULAR), The American College of Rheumatologists (ACR), and Indian Association of Orthopaedic Rheumatology - Indian Orthopaedic Association (IORA-IOA). SARS-CoV-2 pandemic has put enormous pressure on patients with Rheumatic Diseases (RD) due to their innate weakness and shared treatment protocols in management. Though RD
needs a multidisciplinary approach, which remains a challenge in this pandemic scenario, these strategic recommendations would aid in their optimal care amidst the adversity of SARS-CoV-2.
Keywords: Orthopaedic Rheumatology, SARSCoV2, COVID19, Rheumatic Diseases.